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E 
Abstract It has been proposed that TNF cytotoxicity is medi- 
ated by reactive oxygen intermediates generated by uncoupling 
of mitochondrial respiration. We have compared sensitive U937 
cells and derived cell lines depleted of mtDNA for their ability 
to undergo TNF- and Fas-induced apoptosis. Cells lacking 
around 98% of mtDNA were still sensitive to TNF-induced apop- 
tosis. U937 cells devoid of mtDNA (U937-p °) were resistant o 
TNF, but this was due to the loss of its 55 kDa receptor. U937-p ° 
cells were also resistant o docosahexaenoic acid, which causes 
U937 cell death by lipid peroxidation. These cells were sensitive 
to anti-Fas toxicity. The results indicate that TNF and Fas- 
induced toxicity occurs by a mechanism mostly independent of 
mitochondrial free radical generation. 
The mechanism by which Fas ligation triggers apoptosis, as 
well as a general biochemical mechanism for the apoptosis 
process itself, are unknown [5]. Some reports have suggested, 
however, the lack of implication of oxidative damage in cyto- 
toxicity induced with anti-Fas, using antioxidants [14,15] or 
anaerobic conditions [16]. 
In the present work, we have studied the effect of TNF and 
anti-Fas on U937 cells and in derived cell lines depleted of 
mtDNA by prolonged exposure to low doses of ethidium bro- 
mide. Results indicate that impairment of mitochondrial func- 
tion and lipid peroxidation do not play a key role in the apop- 
tosis induced by both molecules in human myeloid cells. 
K~v words: Polyunsaturated fatty acid; Apoptosis; 
Tumor necrosis factor; Fas; mtDNA 
I. Introduction 
Fhe 55 kDa TNF-receptor and Fas/APO-1 (CD95) belong 
to a family of surface receptors that also include the NGF 
receptor, CD40, CD27, 4-1BB and OX40 [1]. While most recep- 
tors of this family are implicated in proliferative processes, 
TNF receptor and Fas, when cross-linked by antibodies or their 
physiological ligands (TNF or the Fas ligand, respectively), 
frequently induce apoptosis [2-5]. TNF has a main role in 
inflammatory esponses [4] while Fas-mediated apoptosis par- 
ticipates in the effector function of cytotoxic T-lymphocytes 
[6,"], as well as in the auto-elimination f activated mature 
T-~ells, and hence, in peripheral tolerance [5,8,9]. 
Oxidative damage has been implicated in some forms of 
TNF-mediated cytotoxicity [4]. Between 1% and 5% of the 
oxygen consumed by mitochondria s converted to damaging 
free radicals [10] and, at least in TNF-induced eath of L929 
cels, the lack of mitochondrial function abolish TNF toxicity 
[11]. However, it should be noted that TNF induces necrotic 
death in L929 cells, while in U937 cells it induces apoptosis [12]. 
Previous work of our group showed that docosahexaenoic acid 
(D HA) enhanced TNF toxicity on U937 cells by increasing the 
amount of lipid peroxidation products. However, although this 
polentiating effect was prevented by antioxidant treatments, 
TNF cytotoxicity itself was not abolished [13]. 
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Abbreviations." TNF, tumor necrosis factor; anti-Fas, cytotoxic mono- 
clonal anti-Fas antiboby; DHA, docosahexaenoic acid; MTT, 3-[4,5- 
dimethylthiazol]-2,5-diphenyl-tetrazolium bromide. 
2. Materials and methods 
2.1. Materials 
4,7,10,13,16,19-Docosahexaenoic acid (DHA), 3-[4,5-dimeth- 
ylthiazol-2-yl]-2,5-diphenyl-tetrazolium br mide (MTT), dimethylsul- 
foxide, ethidium bromide (EtBr), amytal, rotenone and the- 
noyltrifluoroacetone (TTFA) were products from Sigma (Spain). 
Tumor necrosis factor-c~ (TNF) was kindly provided by The National 
Biological Standards Board (UK). Mouse monoclonal IgM antibody 
(clone CH- 11 ), specific for human Fas [17], was from UBI (Lake Placid, 
USA). 
2.2. Generation of U937 cells without mtDNA ( U937-p °) 
Human promonocytic leukemia U937 cells were kindly provided by 
Dr. Jeremy Brock (Department of Immunology, University of 
Glasgow, UK). Cells were routinely cultured at 37°C, in a humidified 
atmosphere containing 5% CO2, using RPMI 1640 medium plus 10% 
fetal calf serum, 2mM L-glutamine, 100 U/ml penicillin, and 100/~g/ml 
streptomycin (hereafter complete medium). Selective limination of 
mtDNA was achieved by long-term exposure to low concentrations (50 
ng/ml) of EtBr essentially asdescribed by King and Attardi [18]. Selec- 
tion and culture medium of U937-p ° cells was also supplemented with 
glucose (4.5 mg/ml), sodium piruvate (0.1 mg/ml) and uridine (50 pg/ 
ml). After 15 weeks of incubation with EtBr, the sensitivity of cells to 
TNF was analyzed by the MTT-reduction method and their mtDNA 
content by PCR as described below. Treatment with EtBr was pro- 
longed for another 20 weeks. The extent of cell differentiation was 
measured by the nitro-blue tetrazolium (NBT) reduction method [19]. 
2.3. mtDNA analysis 
Cells were harvested and the DNA was extracted by the phenol/ 
chloroform ethod, as described elsewhere [20]. mtDNA amplification 
was performed by PCR, using the following set of primers: np 3148- 
3167 (forward) 5'-CCTACTTCACAAAGCGCCTT-3' and np 3531- 
3550 (reverse) 5'-CGATGGTGAGAGCTAAGGTC-Y (nucleotide 
numbering according to [20]). The 403 bp amplified fragment was 
analyzed by electrophoresis on 2% agarose. The bands were visualized 
under UV light in the presence of EtBr and photographed. 
2.4. Cell proliferation assays 
U937 and U937-p ° cells were seeded in flat-bottomed, 96-well plates 
at an initial density of 2 × 105 cells/ml (I00 gl/well), and cultured for 
48-72 h in control medium or medium containing different concentra- 
tions of one or several of the following molecules: DHA (60-120 gM), 
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Fig. 1. Agarose gel electrophoresis of PCR-amplified products from 
mtDNA. Total DNA was purified and amplified using specific primers 
as described in section 2. 1 = control (no template); 2 = DNA molecu- 
lar weight markers; 3= amplified products from U937-p ° cells; 4 = am- 
plified products from U937 cells; 5 = amplified products from U937 
cells treated with 50 ng/ml EtBr for 15 weeks. 
TNF (5-100 U/ml), anti-Fas (500 ng/ml). In the latter case, wells were 
coated with anti-Fas overnight prior to the addition of the cell suspen- 
sion. DHA was added to the medium bound to bovine albumin as 
described in detail in [21]. Mitochondrial electron-chain uncouplers, 
dissolved in ethanol (amytal, TTFA) or dimethyl sulfoxide (rotenone), 
were added to cultures lh before the addition of TNF. Final concentra- 
tion of organic solvents was 0.1% and did not affect cell growth. Cul- 
tures containing the same amounts of drugs, without TNF, were used 
as controls. Cell proliferation was determined by a modification of the 
MTT-reduction method, as previously described [21,22]. U937-p ° cells, 
in spite of the lack of functional mitochondria, can also reduce 
MTT [231. 
2.5. Flow cytometry analysis 
The expression of Fas and the 55 kDa TNF-receptor on the mem- 
brane of U937 and U937-p ° cells was analysed by flow cytometry. For 
TNF-receptor expression, cells were incubated on ice for 1 h with the 
mouse anti-55 kDa TNF-receptor antibody H398 (Bender Medsystems, 
Germany) and revealed with a FITC-labeled goat anti-mouse IgG 
(Caltag, San Francisco, CA). For Fas expression, cells were stained for 
1 h with the CH-11 anti-Fas, and revealed with a FITC-labeled goat 
anti-mouse IgM (Sigma). After fixing in 1% paraformaldehyde, 5,000 
cells were analysed by flow cytometry using a FACScan (Becton and 
Dickinson) and Lysis-II software. 
3. Results 
3.1. Characterization of U937-p ° cells 
To test the involvement of mitochondrial function in apop- 
totic processes, U937 cells were depleted of mtDNA by contin- 
uous exposure to 50 ng/ml EtBr. After an initial period of 
reduced cell growth, cells regained progressively the prolifera- 
tion capacity and by the 15th week of treatment growth rate 
was only slighty lower than that of wild-type U937 cells. They 
exhibited a normal morphology by light microscopy (data not 
shown). The mtDNA content in these cells was reduced by 
around 98% when compared with normal U937 cells (Fig. 1). 
After further culture in the presence of EtBr for another 20 
weeks, cells were entirely devoid of mtDNA (Fig. 1) and were 
designated as U937-p °. These cells showed some signs of cell 
differentiation, such as adhesion to plastic (Fig. 2D) and super- 
oxide generation (31% of U937-p°cells were positive for NBT- 
staining). They were also critically dependent on anaerobic 
glucolysis for survival, since addition of the anti-metabolite 
2-deoxyglucose (10 mM) to the culture medium caused a pro- 
gressive cell death, whereas it had no effect on U937 cells (data 
not shown). 
3.2. Effect of  docosahexaenoic a id on growth of  U937 and 
U937-p ° cells 
Polyunsaturated fatty acids, and especially DHA,  are cyto- 
toxic to human leukemic ell lines through the induction of lipid 
Fig. 2. Effect of incubation with TNF and DHA on growth of U937 (A-C) and U937-p ° (D-F) cells. (A and D) Control cells. (B and E) Cells treated 
with 60/.tM and 120/~M DHA, respectively, for 72 h. (C) Cells incubated with TNF (20 U/ml) for 72 h; and (F) with 100 U/ml TNF for 96 h. 
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Fi:,~. 3. Effect of TNF on proliferation of U937 cells (closed circles), 
U'37 cells treated with EtBr for 15 weeks (open circles) and U937-p ° 
ce ls (open squares). Cells were incubated in the presence ofTNF for 
72 h and cellular growth estimated by the MTT-reduction assay. 
pcroxidation processes [13,21]. Supplementation of U937 cells 
w~th 60/IM DHA for 72 h caused massive cell death (Fig. 2B). 
This effect was prevented by the simultaneous supplementation 
wth 25 ~M vitamin E ([13], and data not shown). However, 
U')37-p ° cells were completely insensitive to the toxic effect of 
Di-IA (up to 120/~M), which only induced a typical fusiform 
m)rphology in these cells (Fig. 2E). 
3. ~. Effect of  TNF  and anti-Fas on growth of  U937 and 
U937-p ° cells 
U937 cells were highly sensitive to TNF-induced apoptosis 
([ igs. 2C and 3). Inhibitors of mitochondrial-chain complex I 
(a~nytal, rotenone) did not offer a significant protection while 
th:,' complex |I inhibitor TTFA partially, but significantly 
(t~< 0.005, two-tailed, Student -test), lowered TNF-induced 
to dcity on U937 cells (Fig. 4). Cells treated with EtBr for 15 
w~ eks, containing around 2% of the amount of mtDNA present 
in wild type cells, were still sensitive to TNF cytotoxicity (Fig. 
3) However, TNF did not inhibit but rather stimulated at low 
d~ses the growth of U937-p ° cells (Fig. 3). After 96 h of incu- 
b~tion with 100 U/ml TNF, U937-p ° cells appeared lengthened 
bl+t no dead cells were observed in cultures (Fig. 2F). The 
ex ~ression of the cytotoxic 55 kDa TNF-receptor was analyzed 
in these cells by flow cytometry. Most U937 and U937 cells 
tr,.ated with EtBr for 15 weeks expressed similar amounts of 
55 kDa TNF-receptor (mean fluorescence intensity 12.1 and 
119, respectively), while less than 1% of U937-p ° cells were 
sp ,'cifically stained, indicating the loss of surface xpression of 
th s receptor. 
Fas-mediated apoptosis was evaluated in wild-type or 
m~ DNA-depleted U937 cells. Contrary to others [14,15], we did 
n~,t use the inhibitor of transcription, actinomycin D, to poten- 
ti~te anti-Fas toxicity on U937 cells, as treatment with actino- 
m',cin D alone was highly toxic for those cells, inducing a 
ty!fical apoptotic process (data not shown). After 24 h incuba- 
ti~ n with anti-Fas, most of U937 cells died, while growth of 
U )37-p ° cells was only slightly depressed (Fig. 5). However, 
growth of U937-p ° cells became progressively inhibited at 
longer times, reaching a 60% inhibition of cellular growth after 
72-96 h of culture with anti-Fas. Flow cytometry analysis re- 
vealed no significant differences in Fas surface xpression be- 
tween U937 and U937-p ° cells (data not shown). 
4. Discussion 
The currently proposed mechanism of signal transduction 
for the intracellular p opagation ofthe cytotoxic signal of TNF 
is mainly based in the works of Fiers et al., carried out with the 
murine fibrosarcoma cell line L929 [2,4,11]. Essentially, this 
mechanism proposes that TNF-induced events interfere with 
normal electron flow in the mitochondria, leading to the gener- 
ation of reactive oxygen intermediates. These oxygen radicals 
would cause cell damage by inducing membrane lipid peroxida- 
tion and triggering the program of cell death. According to this 
hypothesis, TNF cytotoxicity on L929 cells can be partially 
prevented by BHA, a synthetic lipid antioxidant, some types of 
iron chelators and inhibitors of mitochondrial e ectron trans- 
port complexes I and II [2]. Furthermore, L929 cells depleted 
of mtDNA are resistant to TNF-induced necrosis [11]. How- 
ever. it is unclear if this mechanism could be extrapolated to
cell types which undergo apoptosis in response to TNF, such 
as U937 promonocytic cells [12]. 
Our present results how that U937-p ° cells, devoid of func- 
tional mitochondria, re resistant to the cytotoxic effects of 
DHA, a highly polyunsaturated fatty acid that induces lipid 
peroxidation and kills cells by necrosis [13,21]. These, as well 
as other data [10], support he implication of mitochondria n
necrotic ell death induced by oxidative stress. 
Contrary to that observed in L929 cells [2,4,11], treatment 
with mitochondrial inhibitors and reduction in the mtDNA 
content by around 98% did not prevent TNF toxicity in U937 
cells. However, it should be noted that there was no correlation 
between the amount of mtDNA and the sensitivity to TNF 
among the different mtDNA defficient L929 subclones and no 
evaluation of the amount of TNF-receptors in wild-type and 
L929-p ° cells was performed [1 l]. U937-p ° cells were insensi- 
tive to TNF, but this cannot be attributed to the loss of mito- 
chondrial function but to the complete down-modulation f the 
55 kDa TNF receptor. The loss of the 55 kDa TNF-receptor 
+ Rotenone 
+ Amytal / ' rTFA 
+ TTFA 
+ Amytal  
TNF 
0 10 20  30  40  5'0 60  
Cellular Growth (% of control) 
Fig. 4. Effect of mitochondrial chain inhibitors on TNF cytotoxicity. 
U937 cells were preincubated for I h with either amytal (200/IM), 
TTFA (25 ,uM) or rotenone (100 nM), as indicated. Then, TNF (10 
U/ml) was added to the cultures and cell proliferation was determined 
by the MTT-reduction assay after 47 h of further incubation. 
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Fig. 5. Time-course effect of treatment with anti-Fas on growth ofU937 
(circles) and U937-p ° cells (squares). Cells were incubated in 96-well 
plates pre-coated with anti-Fas antibody (500 ng/ml) for the times 
indicated. Cellular growth was estimated by the MTT-reduction assay. 
occurs early during monocytic differentiation [24] and agrees 
with the partially differentiated phenotype of U937-p ° cells. 
The presence of a sequence homology in the cytoplasmic 
region of Fas and the 55 kDa TNF receptor necessary to induce 
cell death, the death domain, led to speculate that both recep- 
tors may trigger apoptosis by similar mechanisms [5,25]. How- 
ever, other studies suggested that this was not the case, since 
some cell types expressed both molecules but were sensitive to 
TNF and insensitive to anti-Fas lysis, or vice versa [26]. In the 
present study we show that anti-Fas significantly inhibits the 
growth of U937-p ° cells. This agrees with recent data on the 
lack of effect of antioxidants [14,15] or anaerobic onditions 
[16] on anti-Fas induced apoptosis. Nevertheless, we observe 
a significant difference in sensitivity to anti-Fas toxicity be- 
tween wild-type and p° cells. These data suggest that, although 
mitochondrial free radical generation isnot necessary per se for 
anti-Fas toxicity, there could be a contribution of this system 
to accelerate or potentiate it. Further studies are being con- 
ducted in our laboratory using activated T cell effectors that 
express the physiological Fas ligand on their surface to evaluate 
this question. 
In summary, we demonstrate that mtDNA-depleted U937 
cells are still sensitive to TNF  and anti-Fas toxicity, indicating 
that mitochondrial generation of reactive oxygen intermediates 
is not the main component in the apoptotic processes initiated 
by those receptors. Other signalling pathways, like the activa- 
tion of intracellular proteases, such as interleukin-lfl convert- 
ing enzyme (ICE), recently demonstrated to be involved in 
Fas- [27,28] and TNF-  [27] induced apoptosis, could represent 
the necessary cytoplasmic event o trigger cell death. The acti- 
vation of an sphingomyelinase that produces the lipid mediator 
ceramide has been described after both Fas [29] and TNF 
receptor engagement [30]. The connection between membrane 
receptor engagement and ICE activation is still unknown, 
although the ceramide-activated pathway could be a common 
candidate for both receptors. In this regard, we have observed 
that administration of synthetic or natural ceramide induces 
apoptosis in U937 and p° cells (unpublished ata). Thus, p° 
cells, resistant o oxidative damage, posses the ceramide-acti- 
vated apoptotic machinery intact and could be a suitable model 
to study this pathway. 
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